Management of Nonmalignant Tracheo- and Bronchoesophageal Fistula after Esophagectomy.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 3 3 2020
medline: 20 5 2021
entrez: 2 3 2020
Statut: ppublish

Résumé

Tracheo- or bronchoesophageal fistula (TBF) occurring after esophagectomy represent a rare but devastating complication. Management remains challenging and controversial. Therefore, the purpose of this study was to evaluate the outcome of different treatment approaches and to propose recommendations for the management of TBF. From 2008 to 2018, 15 patients were treated because of TBF and were analyzed with respect to fistula appearance, treatment strategy (stenting, endoscopic vacuum therapy and/or surgical reintervention) and outcome. In each case, the fistula was small, located close to the tracheal bifurcation and associated simultaneously ( Fistula appearance was similar in all patients. Implementation of esophageal stents cannot be recommended because of possibility of TBF at a later time point. Surgery is usually required and should preferably be performed when the patient's condition has been optimized at a single-stage repair. Esophageal diversion can only be recommended in patients with persisting mediastinitis. The key element for successful treatment of TBF, however, is control over sepsis; otherwise, outcome of TBF is devastating.

Sections du résumé

BACKGROUND
Tracheo- or bronchoesophageal fistula (TBF) occurring after esophagectomy represent a rare but devastating complication. Management remains challenging and controversial. Therefore, the purpose of this study was to evaluate the outcome of different treatment approaches and to propose recommendations for the management of TBF.
METHODS
From 2008 to 2018, 15 patients were treated because of TBF and were analyzed with respect to fistula appearance, treatment strategy (stenting, endoscopic vacuum therapy and/or surgical reintervention) and outcome.
RESULTS
In each case, the fistula was small, located close to the tracheal bifurcation and associated simultaneously (
CONCLUSION
Fistula appearance was similar in all patients. Implementation of esophageal stents cannot be recommended because of possibility of TBF at a later time point. Surgery is usually required and should preferably be performed when the patient's condition has been optimized at a single-stage repair. Esophageal diversion can only be recommended in patients with persisting mediastinitis. The key element for successful treatment of TBF, however, is control over sepsis; otherwise, outcome of TBF is devastating.

Identifiants

pubmed: 32114691
doi: 10.1055/s-0039-1700970
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216-222

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflict of interest.

Auteurs

Daniel Palmes (D)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Linus Kebschull (L)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Ralf Bahde (R)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Norbert Senninger (N)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Andreas Pascher (A)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Mike G Laukötter (MG)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Ann-Kathrin Eichelmann (AK)

Department of General, Visceral and Transplant Surgery, University Hospital of Muenster, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH